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The photosensitizer, mono-L-aspartyl chlorin e6 (NPe6), specifically accumulates in the
atheromatous plaque. We detected the fluorescence spectra of NPe6 emitted from
atheromatous plaques on the descending thoracic aorta by an angioscopic approach using
the animal model of atherosclerosis. We also showed that a fluorescence spectrum peak at
675nm was obtained laparoscopically only in parts of the abdominal aorta with an
atheromatous plaque. By a fluorescence endoscope, atheromatous plaques on the carotid
artery were recognized as reddish spots from outside the artery. In addition, we visualized
specifically at the beating heart surface small coronary atherosclerosis using an epifluores-
cence stereoscope system.
We examined the effects of photodynamic treatment with NPe6 on the atheromatous
plaque. The change in the elastic framework in the atheromatous plaque after photodynamic
treatment was evaluated using scanning electron microscopy. The destruction of the
architecture of the elastic fiber network in the atheromatous plaque was revealed. We also
studied the change in the lipid components of the atheromatous plaque using Fourier
transform infrared (FTIR) microspectroscopy. FTIR microspectroscopic analysis showed
a dissociation of ester bonds of cholesterol esters in the atheromatous plaque after
photodynamic treatment. The framework of the atheromatous plaque and the lipids
accumulated in the plaque could be destroyed following such treatment.
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INTRODUCTION
Accumulation of several compounds in the por-
phyrin group such as hematoporphyrin derivative
(HpD), dihematoporphyrin ether (DHE, Photofrin
II)andhydroxyethyl-vinyldeuteroporphyrin(HVD)
in atherosclerotic lesions has been reported [1-4].
Although these porphyrin compounds were consi-
dered useful for detecting atheromatous plaques,
limitations related to clinical applications such as
marked photosensitization of the skin have been
pointed out.
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Recently, it was shown that mono-L-aspartyl
chlorin e6 (NPe6) accumulates specifically and
rapidly in atheromatous plaques [5]. Intravenously
injected NPe6 disappears with a high clearance rate,
making it unlikely to photosensitize the skin. This
would make NPe6 a better photochemical material
for clinical use than the porphyrin group.
We demonstrated that atherosclerotic lesions
could be recognized by analysis of NPe6 fluores-
cence from within the arterial lumen as well as
outside the artery. Then, we showed the effects of
photodynamic treatment using NPe6 on atheroma-
tous plaques histologically and biochemically.
METHODS
Thirty-five New Zealand white rabbits were fed an
atherogenic diet containing 0.5% cholesterol for 20
weeks. The photosensitizer, NPe6, was adminis-
tered intravenously into an ear vein of atheroscle-
rotic rabbits at a dose of 0.5 mg/kg of body weight
for photodynamic diagnosis (n 20) and 5 mg/kg
for photodynamic treatment (n 15). At 6 h after
intravenous injection of NPe6, the vessel was irra-
diated with a diode laser at a wavelength of 664 nm.
The laser power at the catheter tip was controlled
to 50mW for photodynamic diagnosis and to
150mW for photodynamic treatment.
For photodynamic diagnosis, the fluorescence
spectra from the aorta were measured by a fluores-
cence spectrum analysis system with a dual real time
imaging system and a flexible endoscopic catheter
[6]. The atheromatous plaque on the carotid artery
was checked using a fluorescence endoscope. An
epifluorescence stereoscope system was used to vi-
sualize atherosclerosis in small coronary arteries [7].
For photodynamic treatment, the energy admi-
nistered ranged from 50 to 200 J/cm
2 of the tissue
fluence. The animals were sacrificed by injecting
an overdose of pentobarbital 24 h after the photo-
dynamic treatment. The vessel treated was then exci-
sed. The effects of photodynamic treatment on the
elastic fiber network were evaluated using scanning
electron microscopy in parts of the vessel digested
by a modified hot alkaline method [8]. Tissue
samples were also prepared for Fourier transform
infrared (FTIR) microspectroscopic analysis [9].
RESULTS
The specific fluorescence spectrum peak at 675 nm
of NPe6 was detected only in the parts of the
abdominal aorta with an atheromatous plaque from
outside the adventitia by a laparoscopic approach.
It was also noted that the fluorescence spectrum at
675 nm was obtained angioscopically from inside
the thoracic aorta only in parts with an atheroma-
tous plaque (Fig. 1).
An atheromatous plaque on the carotid artery
was observed as a reddish spot using a fluorescence
endoscope (Fig. 2).
It was unable to specify the parts of the coronary
arteries which had atherosclerotic changes on the
beating heart surface under room light with the
naked eye. However, several brightly illuminated
branching small coronary arteries were observed
clearly against the dark heart surface through the
epifluorescence stereoscope (Fig. 3).
Scanning electron microscopic observation re-
vealed damage to the elastic fiber network in athero-
matous plaques that was exposed to the laser at
6 h after NPe6 administration, but no significant
changes were observed in laser-treated plaques in
animals that did not receive the NPe6 pretreatment
(Fig. 4).
The infrared spectra measured in the atheroma-
tous plaque using FTIR microspectroscopy exhib-
ited characteristic peaks ofcholesterol ester at 1738,
1468, 1380 and 1174cm-1. A marked decrease in
the peak intensity at 1738 cm-1, which was related
to the =C=O ester bond of cholesterol ester, was
observed in the treated atheromatous plaques by
FTIR microspectroscopic analysis (Fig. 5).
DISCUSSION
NPe6 accumulated in the atherosclerotic plaque is
activated by a laser beam at a wavelength of 664nmFIGURE The specific spectrum of NPe6 at 675nm of wavelength obtained from the atheromatous plaque (asterisk) in the
aortic cavity by a fluorescence analysis system with the angioscope.
FIGURE 2 The left carotid artery (arrows) was shown
under room light with the naked eye (upper panel). The athero-
sclerotic lesion was visualized as a reddish spot through the
fluorescence endoscope (lower panel).
FIGURE 3 Atherosclerosis in small coronary arteries was
visualized by an epifluorescence stereoscope system.194 J. HAYASHI et al.
FIGURE 4 Scanning electron micrographs of the lumen of the carotid artery from an untreated rabbit (upper panel) and from
a rabbit with photodynamic treatment (lower panel). The untreated atheromatous plaque appears like a hillock on the internal
elastic lamina. The architecture of the atheromatous plaque was destroyed after photodynamic treatment. Bar in each panel
indicates 500 tm.
that corresponds to the absorption band of NPe6,
then NPe6 emits a fluorescence at 675nm of
wavelength. The exciting beam and the emitting
fluorescence effectively penetrate the tissue. Thus,
we previously reported that NPe6 in the atheroma-
tous plaque was activated from the adventitia of the
vessel and detected from outside the vessel [6,7]. In
the present study, we demonstrated that the pres-
ence and extent of atheromatous plaques was
recognized on the several types of the artery. Such
information suggests that photodynamic diagnosis
with an endoscopic approach may help assess the
clinical significance of atherosclerosis.
The principle underlying photodynamic treat-
ment for atherosclerosis is the activation, by laser
irradiation, of a photosensitizer that is selectively
localized in the atheromatous plaque. The athero-
matous plaque, as well as the arterial wall, contains
a network of elastic fibers which serves as a main
framework to keep morphological structure ofPDD AND PDT FOR ATHEROSCLEROSIS 195
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FIGURE 5 Infrared absorption spectra obtained from the non-treated atheromatous plaque showed the specific peak at
1738cm
-1 (arrow). After photodynamic therapy with NPe6, the peak intensity at 1738cm
-I was decreased (asterisk).
these tissues. The hot alkaline digestion method is
useful in that it removes the non-elastic tissue while
preserving the elastic elements, thus allowing one to
observe the elastic fiber network following photo-
dynamic treatment [8]. We demonstrated that
atheromatous plaques of the carotid artery can be
selectively degraded by laser irradiation following
pretreatment with the photosensitizer, NPe6. In
addition, FTIR microspectroscopic analysis is use-
ful to detect changes in the chemical structure of
lipids accumulated in the atheromatous plaque [9].
We showed a dissociation of ester bonds of choles-
terol esters, the lipids accumulated in the athero-
matous plaque, after photodynamic treatment.
Findings suggest that photodynamic treatment
with NPe6 on the atheromatous plaque could be an
effective clinical approach to regress atherosclerosis.
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